STEM CELL PRICING debate is now out of the gate, and promises to be controversial. This will test the proposition that the (potential) reversal of severe chronic diseases will save the healthcare system a lot of money, and test our willingness as a society to reward that saving with some kind of public insurance payment. ”
”
http://lnkd.in/zYeshK
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022